Response to thalidomide therapy in refractory chronic graft-versus-host disease (Q73197253)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081386%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Response to thalidomide therapy in refractory chronic graft-versus-host disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081386%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Browne PV

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081386%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Weisdorf DJ

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081386%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

DeFor T

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081386%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Miller WJ

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081386%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Davies SM

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081386%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Filipovich A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081386%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

McGlave PB

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081386%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Ramsay NK

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081386%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Wagner J

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081386%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Enright H

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081386%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 October 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081386%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081386%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081386%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081386%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

865-869

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081386%20AND%20SRC:MED&resulttype=core&format=json

Effect of Thalidomide on the Graft versus Host Reaction

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702626

7 January 2021

Thalidomide for graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702626

7 January 2021

Thalidomide treatment for chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702626

7 January 2021

Thalidomide for the treatment of chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702626

7 January 2021

The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702626

7 January 2021

Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702626

7 January 2021

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702626

7 January 2021

Thalidomide in leprosy reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702626

7 January 2021

Thalidomide-induced toxic epidermal necrolysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702626

7 January 2021

Thalidomide in children undergoing bone marrow transplantation: series at a single institution and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702626

7 January 2021